Q3 2018

Source filing unavailable

Q3 2018 · —

Revenue

€4.06B

−6.4% vs Q3 2017

Net Income

€284.61M

−8.0% vs Q3 2017

EPS Diluted

€0.93

−7.9% vs Q3 2017

Gross Profit€1,267,346,000−11.0%

Operating Income€526,722,000−13.5%

Operating Cash Flowderived

Same quarter

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Fresenius Medical Care AG · CIK 1333141 · Engraved from SEC EDGAR